Telo Genomics Corp.
TELO.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.93M | -1.94M | -1.87M | -1.73M | -1.91M |
| Total Depreciation and Amortization | 8.40K | 10.40K | 14.70K | 20.00K | 25.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 236.30K | 236.30K | 125.20K | -35.40K | 10.40K |
| Change in Net Operating Assets | 152.70K | 38.20K | 35.60K | 314.00K | 226.00K |
| Cash from Operations | -1.53M | -1.66M | -1.70M | -1.43M | -1.64M |
| Capital Expenditure | -3.80K | -2.30K | -4.00K | -1.70K | -1.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.80K | -2.30K | -4.00K | -1.70K | -1.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | -22.50K | -22.50K |
| Issuance of Common Stock | 2.55M | 2.55M | 3.20M | 3.20M | 650.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -220.50K | -220.70K | -258.90K | -258.40K | -38.40K |
| Cash from Financing | 1.66M | 1.66M | 2.11M | 2.09M | 430.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.30K | 200.00 | 409.00K | 657.40K | -1.22M |